OptimizeRx
OPRX
153 hedge funds and large institutions have $585M invested in OptimizeRx in 2022 Q1 according to their latest regulatory filings, with 20 funds opening new positions, 65 increasing their positions, 49 reducing their positions, and 47 closing their positions.
41% more call options, than puts
Call options by funds: $23.8M | Put options by funds: $16.9M
33% more repeat investments, than reductions
Existing positions increased: 65 | Existing positions reduced: 49
2.4% more ownership
Funds ownership: 84.39% → 86.79% (+2.4%)
15% less funds holding
Funds holding: 180 → 153 (-27)
37% less capital invested
Capital invested by funds: $931M → $585M (-$345M)
40% less funds holding in top 10
Funds holding in top 10: 5 → 3 (-2)
57% less first-time investments, than exits
New positions opened: 20 | Existing positions closed: 47
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
SCA
Summit Creek Advisors
Minneapolis,
Minnesota
|
+$9.61M |
| 2 |
GIP
Granite Investment Partners
El Segundo,
California
|
+$8.35M |
| 3 |
American Century Companies
Kansas City,
Missouri
|
+$7.25M |
| 4 |
GIPM
G2 Investment Partners Management
New York
|
+$5.69M |
| 5 |
Northern Trust
Chicago,
Illinois
|
+$4.16M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
CHM
Collaborative Holdings Management
New York
|
-$10.1M |
| 2 |
Point72 Asset Management
Stamford,
Connecticut
|
-$9.01M |
| 3 |
CM
Castleark Management
Chicago,
Illinois
|
-$7.07M |
| 4 |
WA
Wasatch Advisors
Salt Lake City,
Utah
|
-$5.79M |
| 5 |
VCM
Venator Capital Management
Toronto,
Ontario, Canada
|
-$3.08M |
OPRX Hedge Fund Activity: Q1 2022 in Review
153 of the 6,360 institutional investors tracked by Wall St. Rank reported a position in OptimizeRx (OPRX) for Q1 2022, worth a combined $585M — down 37% from $931M a quarter earlier.
Sellers outnumbered buyers: 47 funds closed out of OPRX and 20 opened new positions — a net loss of 27 holders — while 49 trimmed existing stakes and 65 added.
The largest buyer was Summit Creek Advisors, opening a new position worth an estimated $9.61M. The largest seller was Collaborative Holdings Management, exiting entirely with an estimated $10.1M sold.
- 153 institutional investors held OptimizeRx (OPRX) as of Q1 2022, down from 180 in Q4 2021.
- Funds reported $585M of OptimizeRx stock for Q1 2022, down 37% quarter-over-quarter.
- 20 funds opened new OptimizeRx positions in Q1 2022 and 47 closed out, a net change of -27 holders.
- The largest OptimizeRx buyer in Q1 2022 was Summit Creek Advisors, an estimated $9.61M added.
- The largest OptimizeRx seller in Q1 2022 was Collaborative Holdings Management, an estimated $10.1M sold.
Based on aggregated 13F filings for Q1 2022.